News from the FDA/CDC
News from the FDA/CDC
COVID-19 claims more than 675,000 U.S. lives, surpassing the 1918 flu
In some ways, the United States has failed to learn from the mistakes of the past.
News from the FDA/CDC
Moderna vaccine more effective than Pfizer and J&J
“Understanding differences in [vaccine effectiveness] by vaccine product can guide individual choices and policy recommendations regarding vaccine...
News from the FDA/CDC
Even those who just test positive at more risk for long COVID: CDC
...
News from the FDA/CDC
Three JAK inhibitors get boxed warnings, modified indications
The FDA is limiting all approved uses of tofacitinib, baricitinib, and upadacitinib to patients who have not responded well to TNF blockers, to...
News from the FDA/CDC
CDC panel unanimously backs Pfizer vax, fortifying FDA approval
The risk of myocarditis after a COVID infection was 6 to 34 times higher than the risk after receiving an mRNA vaccine.
News from the FDA/CDC
FDA fully approves Pfizer COVID-19 vaccine
News from the FDA/CDC
CDC officially endorses third dose of mRNA vaccines for immunocompromised
Just hours after the FDA updated its EUA for COVID vaccines, the CDC has recommended a third dose for those who are at higher risk for severe or...
News from the FDA/CDC
Untreatable, drug-resistant fungus found in Texas and Washington, D.C.
News from the FDA/CDC
FDA approves anifrolumab (Saphnelo) as first new lupus treatment in more than 10 years
Anifrolumab, a monoclonal antibody against type 1 interferon receptor, improved overall disease activity in patients with SLE on standard therapy...
News from the FDA/CDC
FDA approves intravenous immunoglobulin for dermatomyositis
Octagam 10% is the first treatment to have an indication specifically for dermatomyositis.
News from the FDA/CDC
Delta becomes dominant coronavirus variant in U.S.